Temazepam 7.5 MG Oral Capsule — RxCUI 198243
RxNorm drug concept · Semantic clinical drug
RxCUI 198243
Semantic clinical drug · SCD
● Current RxNorm concept 38 FDA products
93 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI198243
Official nameTemazepam 7.5 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped38
Package NDCs mapped93
Reported Medicaid activity (SDUD)195,601 prescriptions · 48 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Temazepam: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Temazepam is approved for short-term use only — generally 7 to 10 days. It's not meant to be a long-term sleep solution. If you're still having trouble sleeping after that time, th...
- Please don't. Alcohol and temazepam are both sedatives, and combining them makes the effects of both much stronger — not just extra sleepiness, but real risks like dangerously slow...
- Can I take temazepam with a glass of wine or a beer?
- Stopping temazepam abruptly after taking it regularly — even for a short time — can trigger withdrawal reactions. These can range from rebound insomnia and anxiety to, in more seve...
🕸️ Concept Web — How Temazepam 7.5 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Temazepam 7.5 MG Oral Capsule
RxCUI 198243 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Temazepam
10355IN
-
Temazepam
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Restoril
219641BN
-
Restoril
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Temazepam Oral Capsule
374026SCDF -
Temazepam Oral Product
1164228SCDG -
Temazepam Pill
1164229SCDG -
Temazepam Oral Capsule [Restoril]
93946SBDF -
Restoril Oral Product
1182531SBDG -
Restoril Pill
1182532SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Temazepam Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Temazepam 7.5 MG
316768SCDC -
Temazepam 7.5 MG Oral Capsule [Restoril]
208463SBD -
Temazepam 7.5 MG [Restoril]
569159SBDC
-
Temazepam 7.5 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Temazepam 7.5 MG
SCDC · 316768 -
Temazepam Oral Capsule
SCDF · 374026 -
Temazepam Oral Product
SCDG · 1164228 -
Temazepam Pill
SCDG · 1164229
Brand-Name Concepts
-
Temazepam 7.5 MG Oral Capsule [Restoril]
SBD · 208463 -
Temazepam 7.5 MG [Restoril]
SBDC · 569159 -
Temazepam Oral Capsule [Restoril]
SBDF · 93946 -
Restoril Oral Product
SBDG · 1182531 -
Restoril Pill
SBDG · 1182532 -
Restoril
BN · 219641
📦 FDA Products & Package NDCs
38 products · 93 package NDCs
93 package NDCs map to RxCUI 198243 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00406-9914-03 | 30 CAPSULE in 1 BOTTLE (0406-9914-03) | RESTORIL | SpecGx LLC | 1981-02-27 |
| 00406-9915-01 | 100 CAPSULE in 1 BOTTLE (0406-9915-01) | RESTORIL | SpecGx LLC | 1981-02-27 |
| 00406-9915-03 | 30 CAPSULE in 1 BOTTLE (0406-9915-03) | RESTORIL | SpecGx LLC | 1981-02-27 |
| 00406-9916-01 | 100 CAPSULE in 1 BOTTLE (0406-9916-01) | RESTORIL | SpecGx LLC | 1981-02-27 |
| 00406-9917-01 | 100 CAPSULE in 1 BOTTLE (0406-9917-01) | RESTORIL | SpecGx LLC | 1981-02-27 |
| 00406-9959-03 | 30 CAPSULE in 1 BOTTLE (0406-9959-03) | TEMAZEPAM | SpecGx LLC | 2010-02-23 |
| 00406-9960-01 | 100 CAPSULE in 1 BOTTLE (0406-9960-01) | TEMAZEPAM | SpecGx LLC | 2010-02-23 |
| 00406-9961-01 | 100 CAPSULE in 1 BOTTLE (0406-9961-01) | TEMAZEPAM | SpecGx LLC | 2010-02-23 |
| 00406-9962-01 | 100 CAPSULE in 1 BOTTLE (0406-9962-01) | TEMAZEPAM | SpecGx LLC | 2010-02-23 |
| 00904-6436-04 | 30 BLISTER PACK in 1 CARTON (0904-6436-04) / 1 CAPSULE in 1... | Temazepam | Major Pharmaceuticals | 2015-03-25 |
| 43353-0152-30 | 30 CAPSULE in 1 BOTTLE (43353-152-30) | Temazepam | Aphena Pharma Solutions - Tennessee, LLC | 2016-02-22 |
| 43353-0152-53 | 60 CAPSULE in 1 BOTTLE (43353-152-53) | Temazepam | Aphena Pharma Solutions - Tennessee, LLC | 2016-04-29 |
| 43353-0152-60 | 90 CAPSULE in 1 BOTTLE (43353-152-60) | Temazepam | Aphena Pharma Solutions - Tennessee, LLC | 2016-02-16 |
| 43547-0611-10 | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-611-10) | Temazepam | Solco Healthcare U.S., LLC | 2023-01-05 |
| 43547-0612-10 | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-612-10) | Temazepam | Solco Healthcare U.S., LLC | 2023-01-05 |
| 43547-0612-50 | 500 CAPSULE in 1 BOTTLE, PLASTIC (43547-612-50) | Temazepam | Solco Healthcare U.S., LLC | 2023-01-05 |
| 43547-0613-03 | 30 CAPSULE in 1 BOTTLE, PLASTIC (43547-613-03) | Temazepam | Solco Healthcare U.S., LLC | 2023-01-05 |
| 43547-0614-10 | 100 CAPSULE in 1 BOTTLE, PLASTIC (43547-614-10) | Temazepam | Solco Healthcare U.S., LLC | 2023-01-05 |
| 43547-0614-50 | 500 CAPSULE in 1 BOTTLE, PLASTIC (43547-614-50) | Temazepam | Solco Healthcare U.S., LLC | 2023-01-05 |
| 46708-0379-30 | 30 CAPSULE in 1 BOTTLE (46708-379-30) | Temazepam | Alembic Pharmaceuticals Limited | 2018-11-27 |
| 46708-0379-31 | 100 CAPSULE in 1 BOTTLE (46708-379-31) | Temazepam | Alembic Pharmaceuticals Limited | 2018-11-27 |
| 46708-0380-30 | 30 CAPSULE in 1 BOTTLE (46708-380-30) | Temazepam | Alembic Pharmaceuticals Limited | 2018-11-27 |
| 46708-0380-31 | 100 CAPSULE in 1 BOTTLE (46708-380-31) | Temazepam | Alembic Pharmaceuticals Limited | 2018-11-27 |
| 46708-0380-71 | 500 CAPSULE in 1 BOTTLE (46708-380-71) | Temazepam | Alembic Pharmaceuticals Limited | 2018-11-27 |
| 46708-0380-90 | 90 CAPSULE in 1 BOTTLE (46708-380-90) | Temazepam | Alembic Pharmaceuticals Limited | 2018-11-27 |
| 46708-0381-30 | 30 CAPSULE in 1 BOTTLE (46708-381-30) | Temazepam | Alembic Pharmaceuticals Limited | 2018-11-27 |
| 46708-0382-30 | 30 CAPSULE in 1 BOTTLE (46708-382-30) | Temazepam | Alembic Pharmaceuticals Limited | 2018-11-27 |
| 46708-0382-31 | 100 CAPSULE in 1 BOTTLE (46708-382-31) | Temazepam | Alembic Pharmaceuticals Limited | 2018-11-27 |
| 46708-0382-71 | 500 CAPSULE in 1 BOTTLE (46708-382-71) | Temazepam | Alembic Pharmaceuticals Limited | 2018-11-27 |
| 46708-0382-90 | 90 CAPSULE in 1 BOTTLE (46708-382-90) | Temazepam | Alembic Pharmaceuticals Limited | 2018-11-27 |
| 62332-0379-30 | 30 CAPSULE in 1 BOTTLE (62332-379-30) | Temazepam | Alembic Pharmaceuticals Inc. | 2018-11-27 |
| 62332-0379-31 | 100 CAPSULE in 1 BOTTLE (62332-379-31) | Temazepam | Alembic Pharmaceuticals Inc. | 2018-11-27 |
| 62332-0380-30 | 30 CAPSULE in 1 BOTTLE (62332-380-30) | Temazepam | Alembic Pharmaceuticals Inc. | 2018-11-27 |
| 62332-0380-31 | 100 CAPSULE in 1 BOTTLE (62332-380-31) | Temazepam | Alembic Pharmaceuticals Inc. | 2018-11-27 |
| 62332-0380-71 | 500 CAPSULE in 1 BOTTLE (62332-380-71) | Temazepam | Alembic Pharmaceuticals Inc. | 2018-11-27 |
| 62332-0380-90 | 90 CAPSULE in 1 BOTTLE (62332-380-90) | Temazepam | Alembic Pharmaceuticals Inc. | 2018-11-27 |
| 62332-0381-30 | 30 CAPSULE in 1 BOTTLE (62332-381-30) | Temazepam | Alembic Pharmaceuticals Inc. | 2018-11-27 |
| 62332-0382-30 | 30 CAPSULE in 1 BOTTLE (62332-382-30) | Temazepam | Alembic Pharmaceuticals Inc. | 2018-11-27 |
| 62332-0382-31 | 100 CAPSULE in 1 BOTTLE (62332-382-31) | Temazepam | Alembic Pharmaceuticals Inc. | 2018-11-27 |
| 62332-0382-71 | 500 CAPSULE in 1 BOTTLE (62332-382-71) | Temazepam | Alembic Pharmaceuticals Inc. | 2018-11-27 |
| 62332-0382-90 | 90 CAPSULE in 1 BOTTLE (62332-382-90) | Temazepam | Alembic Pharmaceuticals Inc. | 2018-11-27 |
| 63629-8601-01 | 100 CAPSULE in 1 BOTTLE (63629-8601-1) | temazepam | Bryant Ranch Prepack | 2021-07-13 |
| 65162-0556-03 | 30 CAPSULE in 1 BOTTLE (65162-556-03) | Temazepam | Amneal Pharmaceuticals LLC | 2016-05-23 |
| 65162-0556-10 | 100 CAPSULE in 1 BOTTLE (65162-556-10) | Temazepam | Amneal Pharmaceuticals LLC | 2016-05-23 |
| 65162-0556-11 | 1000 CAPSULE in 1 BOTTLE (65162-556-11) | Temazepam | Amneal Pharmaceuticals LLC | 2016-05-23 |
| 65162-0556-50 | 500 CAPSULE in 1 BOTTLE (65162-556-50) | Temazepam | Amneal Pharmaceuticals LLC | 2016-05-23 |
| 65162-0557-03 | 30 CAPSULE in 1 BOTTLE (65162-557-03) | Temazepam | Amneal Pharmaceuticals LLC | 2016-05-23 |
| 65162-0557-10 | 100 CAPSULE in 1 BOTTLE (65162-557-10) | Temazepam | Amneal Pharmaceuticals LLC | 2016-05-23 |
| 65162-0557-11 | 1000 CAPSULE in 1 BOTTLE (65162-557-11) | Temazepam | Amneal Pharmaceuticals LLC | 2016-05-23 |
| 65162-0557-50 | 500 CAPSULE in 1 BOTTLE (65162-557-50) | Temazepam | Amneal Pharmaceuticals LLC | 2016-05-23 |
Observed labelers:
Asclemed USA, Inc. (20) ·
Amneal Pharmaceuticals LLC (16) ·
Alembic Pharmaceuticals Inc. (11) ·
Alembic Pharmaceuticals Limited (11) ·
Ascend Laboratories, LLC (10) ·
SpecGx LLC (9)
· +5 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.